Chromosomal Aberrations in Leukaemia Cells May Delete Tumour Target Antigens of Stem Cell-Based Immunotherapy

Leukemia - United Kingdom
doi 10.1038/sj.leu.2404237
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cross-Presentation of Tumour Antigens by Human Induced Pluripotent Stem Cell-Derived CD141+XCR1+ Dendritic Cells

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2011English

Stalling Cell Division Keeps Leukaemia Stem Cells Going

Nature Reports Stem Cells
2009English

Landscape of Tumor Antigens in T Cell Immunotherapy

Journal of Immunology
AllergyImmunology
2015English

532. Donor T Cells Specific for Multiple Leukemia Antigens for Adoptive Immunotherapy of Myeloid Leukemias After Stem Cell Transplantation

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Editorial: Fetal Antigens and Tumour Cells.

BMJ
1974English

Targeting Cancer Stem Cells With Natural Killer Cell Immunotherapy

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2016English

Patterns of Chromosomal Aberrations in Solid Tumors

Recent Results in Cancer Research
MedicineCancer ResearchOncology
2015English

Algorithm for Sorting Chromosomal Aberrations

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2018English

Stem Cell Immunotherapy: Local Immune‐Triggered Surface‐Modified Stem Cells for Solid Tumor Immunotherapy (Adv. Funct. Mater. 26/2019)

Advanced Functional Materials
Materials ScienceCondensed Matter PhysicsElectrochemistryNanoscienceOpticalBiomaterialsMagnetic MaterialsNanotechnologyChemistryElectronic
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy